Cargando…

The value of applying a melatonin antagonist (Luzindole) in improving the success rate of the bipedal rat scoliosis model

BACKGROUND: An ideal animal model has always been the key to research the pathogenesis and treatment of adolescent idiopathic scoliosis (AIS), while available methods have obvious disadvantages. The deficiency of melatonin has been proved relating to AIS. In this research, we intended to apply Luzin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shuo, Zheng, Chaojun, Jiang, Jianyuan, Lu, Feizhou, Xia, Xinlei, Zhu, Wei, Jin, Xiang, Ma, Xiaosheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379722/
https://www.ncbi.nlm.nih.gov/pubmed/28376758
http://dx.doi.org/10.1186/s12891-017-1500-x
_version_ 1782519663550267392
author Yang, Shuo
Zheng, Chaojun
Jiang, Jianyuan
Lu, Feizhou
Xia, Xinlei
Zhu, Wei
Jin, Xiang
Ma, Xiaosheng
author_facet Yang, Shuo
Zheng, Chaojun
Jiang, Jianyuan
Lu, Feizhou
Xia, Xinlei
Zhu, Wei
Jin, Xiang
Ma, Xiaosheng
author_sort Yang, Shuo
collection PubMed
description BACKGROUND: An ideal animal model has always been the key to research the pathogenesis and treatment of adolescent idiopathic scoliosis (AIS), while available methods have obvious disadvantages. The deficiency of melatonin has been proved relating to AIS. In this research, we intended to apply Luzindole, the melatonin antagonist, in bipedal rat model, for the block of combination of melatonin and its receptor, to inhibit the melatonin effect, and then to understand whether this method can effectively improve the scoliosis rate of bipedal rat model, and investigate the role of melatonin in scoliosis. To investigate the feasibility of improving the success rate of bipedal rat scoliosis model via intraperitoneal injection of melatonin antagonist (Luzindole). METHODS: A total of 60 3-weeks-old Sprague-Dawley rats were included in this study, and were divided into 3 groups (A, B and C). Each group included 20 rats. Osteotomy of the bilateral proximal humerus and proximal tailbone was performed in group A and group B; intraperitoneal injection of Luzindole (0.2 mg/kg) was performed in group A and group C. X-rays were taken before the surgery, 1 month after the surgery, 3 months after the surgery, and 6 months after the surgery, to calculate the Cobb’s angle of the spine (>10° was considered scoliosis). The weight of every rat was also measured at the same time. Rats were euthanized 6 months after surgery to determine the calmodulin level in thrombocytes. RESULTS: The rate of scoliosis in group A (14/20) was significantly higher than those in group B (6/20) and group C (0/20) (P < 0.05). The differences in the weights of the 3 groups were non-significant; as were differences in the calmodulin level in thrombocytes. CONCLUSION: The application of the melatonin antagonist of Luzindole can improve the success rate of the bipedal rat scoliosis model. Meanwhile, this study indicates that a decreased melatonin level is not the primary cause of scoliosis, but that it may increase the likelihood and severity of scoliosis.
format Online
Article
Text
id pubmed-5379722
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53797222017-04-10 The value of applying a melatonin antagonist (Luzindole) in improving the success rate of the bipedal rat scoliosis model Yang, Shuo Zheng, Chaojun Jiang, Jianyuan Lu, Feizhou Xia, Xinlei Zhu, Wei Jin, Xiang Ma, Xiaosheng BMC Musculoskelet Disord Research Article BACKGROUND: An ideal animal model has always been the key to research the pathogenesis and treatment of adolescent idiopathic scoliosis (AIS), while available methods have obvious disadvantages. The deficiency of melatonin has been proved relating to AIS. In this research, we intended to apply Luzindole, the melatonin antagonist, in bipedal rat model, for the block of combination of melatonin and its receptor, to inhibit the melatonin effect, and then to understand whether this method can effectively improve the scoliosis rate of bipedal rat model, and investigate the role of melatonin in scoliosis. To investigate the feasibility of improving the success rate of bipedal rat scoliosis model via intraperitoneal injection of melatonin antagonist (Luzindole). METHODS: A total of 60 3-weeks-old Sprague-Dawley rats were included in this study, and were divided into 3 groups (A, B and C). Each group included 20 rats. Osteotomy of the bilateral proximal humerus and proximal tailbone was performed in group A and group B; intraperitoneal injection of Luzindole (0.2 mg/kg) was performed in group A and group C. X-rays were taken before the surgery, 1 month after the surgery, 3 months after the surgery, and 6 months after the surgery, to calculate the Cobb’s angle of the spine (>10° was considered scoliosis). The weight of every rat was also measured at the same time. Rats were euthanized 6 months after surgery to determine the calmodulin level in thrombocytes. RESULTS: The rate of scoliosis in group A (14/20) was significantly higher than those in group B (6/20) and group C (0/20) (P < 0.05). The differences in the weights of the 3 groups were non-significant; as were differences in the calmodulin level in thrombocytes. CONCLUSION: The application of the melatonin antagonist of Luzindole can improve the success rate of the bipedal rat scoliosis model. Meanwhile, this study indicates that a decreased melatonin level is not the primary cause of scoliosis, but that it may increase the likelihood and severity of scoliosis. BioMed Central 2017-04-04 /pmc/articles/PMC5379722/ /pubmed/28376758 http://dx.doi.org/10.1186/s12891-017-1500-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Yang, Shuo
Zheng, Chaojun
Jiang, Jianyuan
Lu, Feizhou
Xia, Xinlei
Zhu, Wei
Jin, Xiang
Ma, Xiaosheng
The value of applying a melatonin antagonist (Luzindole) in improving the success rate of the bipedal rat scoliosis model
title The value of applying a melatonin antagonist (Luzindole) in improving the success rate of the bipedal rat scoliosis model
title_full The value of applying a melatonin antagonist (Luzindole) in improving the success rate of the bipedal rat scoliosis model
title_fullStr The value of applying a melatonin antagonist (Luzindole) in improving the success rate of the bipedal rat scoliosis model
title_full_unstemmed The value of applying a melatonin antagonist (Luzindole) in improving the success rate of the bipedal rat scoliosis model
title_short The value of applying a melatonin antagonist (Luzindole) in improving the success rate of the bipedal rat scoliosis model
title_sort value of applying a melatonin antagonist (luzindole) in improving the success rate of the bipedal rat scoliosis model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379722/
https://www.ncbi.nlm.nih.gov/pubmed/28376758
http://dx.doi.org/10.1186/s12891-017-1500-x
work_keys_str_mv AT yangshuo thevalueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel
AT zhengchaojun thevalueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel
AT jiangjianyuan thevalueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel
AT lufeizhou thevalueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel
AT xiaxinlei thevalueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel
AT zhuwei thevalueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel
AT jinxiang thevalueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel
AT maxiaosheng thevalueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel
AT yangshuo valueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel
AT zhengchaojun valueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel
AT jiangjianyuan valueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel
AT lufeizhou valueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel
AT xiaxinlei valueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel
AT zhuwei valueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel
AT jinxiang valueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel
AT maxiaosheng valueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel